Spots Global Cancer Trial Database for stem cells
Every month we try and update this database with for stem cells cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) | NCT01231022 | Breast Neoplasm... Neoplasm Metast... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | ||
| Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients | NCT01010880 | Multiple Myelom... | BKT140 | 16 Years - 65 Years | Biokine Therapeutics Ltd | |
| Cellular Therapy With Cord Blood Cells | NCT00427557 | Multiple Myelom... Leukemia Lymphoma | Fludarabine Melphalan Umbilical Cord ... Rituximab Peripheral Bloo... | - 80 Years | M.D. Anderson Cancer Center | |
| Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients | NCT04776538 | Xerostomia Foll... | Stem cells Placebo | 18 Years - 70 Years | Rigshospitalet, Denmark | |
| Cellular Therapy With Cord Blood Cells | NCT00427557 | Multiple Myelom... Leukemia Lymphoma | Fludarabine Melphalan Umbilical Cord ... Rituximab Peripheral Bloo... | - 80 Years | M.D. Anderson Cancer Center | |
| Changes in Stem Cells of the Colon in Response to Increased Risk of Colorectal Cancer | NCT01075893 | Colorectal Canc... | 18 Years - 85 Years | Newcastle University | ||
| Use of Stem Cells in Lymphedema Post Mastectomy | NCT01112189 | Lymphedema Breast Cancer | Autologous tran... Compressed slee... | 18 Years - 75 Years | Hospital Universitario Dr. Jose E. Gonzalez | |
| A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas | NCT01625351 | Ewing Sarcoma Gastrointestina... Germ Cell Tumor Hepatic Tumor Lymphoma Wilms Tumor Rhabdoid Tumor Clear Cell Carc... Renal Cell Carc... Melanoma Neuroblastoma Rhabdomyosarcom... Non-rhabdomyosa... | alemtuzumab fludarabine sirolimus Busulfan melphalan stem cells CliniMACS | 2 Years - 21 Years | St. Jude Children's Research Hospital | |
| Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients | NCT04776538 | Xerostomia Foll... | Stem cells Placebo | 18 Years - 70 Years | Rigshospitalet, Denmark | |
| Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) | NCT01231022 | Breast Neoplasm... Neoplasm Metast... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | ||
| Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients | NCT01010880 | Multiple Myelom... | BKT140 | 16 Years - 65 Years | Biokine Therapeutics Ltd | |
| Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization | NCT01449539 | Multiple Myelom... | Hyperbaric Oxyg... | 18 Years - | University of Arkansas | |
| Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation | NCT02828878 | Hematological M... | Allogeneic MPBC... | 18 Years - 70 Years | Cellect Biotechnology | |
| Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) | NCT01231022 | Breast Neoplasm... Neoplasm Metast... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | ||
| Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization | NCT01449539 | Multiple Myelom... | Hyperbaric Oxyg... | 18 Years - | University of Arkansas | |
| Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease | NCT01702961 | Lymphoma Hodgkin's Disea... | Melphalan Ara-C VP-16 BCNU Rituxan Stem Cells | - | Baylor College of Medicine | |
| Isolation and Characterization of Mammary Stem Cells | NCT00340392 | Stem Cells | - | National Institutes of Health Clinical Center (CC) | ||
| P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies | NCT01854567 | Acute Myelogeno... Acute Lymphobla... Non-Hodgkin's L... Hodgkin's Disea... | Infusion of one... Infusion of two... | - 65 Years | Mesoblast, Ltd. | |
| CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC. | NCT03381326 | Prostate Cancer Metastatic Canc... Castration-resi... Circulating Tum... | blood and FFPE ... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions | NCT00851162 | Bone Neoplasms | Trinity multipo... Demineralized b... | 11 Years - | Emory University | |
| Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease | NCT01702961 | Lymphoma Hodgkin's Disea... | Melphalan Ara-C VP-16 BCNU Rituxan Stem Cells | - | Baylor College of Medicine | |
| Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders | NCT03198234 | AML - Acute Mye... MDS (Myelodyspl... Mixed Phenotype... NHL - Non-Hodgk... Hodgkin's Lymph... ALL | T-allo10 | 3 Years - 45 Years | Stanford University | |
| T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant | NCT01621477 | Acute Lymphobla... Acute Myelocyti... Chronic Myelocy... Juvenile Myelom... Myelodysplastic... Hodgkin or Non-... Sarcoma, Myeloi... | clofarabine cytarabine busulfan Plerixafor cyclophosphamid... antithymocyte g... stem cells Tacrolimus mycophenolate m... | - 21 Years | St. Jude Children's Research Hospital | |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS | NCT06143527 | Polycystic Ovar... Polycystic Ovar... PCOS | AlloRx | 18 Years - | The Foundation for Orthopaedics and Regenerative Medicine | |
| Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer | NCT03240861 | HLA-A*0201 Posi... Locally Advance... NY-ESO-1 Positi... Unresectable Ma... Sarcoma | 18F-FHBG Aldesleukin Busulfan Cellular Therap... Computed Tomogr... Filgrastim Fludarabine Leukapheresis Plerixafor Positron Emissi... | 16 Years - | Jonsson Comprehensive Cancer Center | |
| T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies | NCT00683046 | Acute Myelogeno... Lymphoid Leukem... Chronic Myeloge... Malignant Lymph... Hodgkin's Disea... Chronic Lymphoc... Myeloproliferat... Anemia, Aplasti... Myelodysplastic... | Fludarabine Melphalan Stem cells Campath | - 100 Years | University of Chicago | |
| Use of Stem Cells in Lymphedema Post Mastectomy | NCT01112189 | Lymphedema Breast Cancer | Autologous tran... Compressed slee... | 18 Years - 75 Years | Hospital Universitario Dr. Jose E. Gonzalez | |
| T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies | NCT00683046 | Acute Myelogeno... Lymphoid Leukem... Chronic Myeloge... Malignant Lymph... Hodgkin's Disea... Chronic Lymphoc... Myeloproliferat... Anemia, Aplasti... Myelodysplastic... | Fludarabine Melphalan Stem cells Campath | - 100 Years | University of Chicago | |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS | NCT06143527 | Polycystic Ovar... Polycystic Ovar... PCOS | AlloRx | 18 Years - | The Foundation for Orthopaedics and Regenerative Medicine | |
| Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer | NCT01015625 | Synchronous Met... Circulating Tum... | Surgery Surgery on Dema... | 18 Years - | Austrian Breast & Colorectal Cancer Study Group | |
| Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer | NCT01015625 | Synchronous Met... Circulating Tum... | Surgery Surgery on Dema... | 18 Years - | Austrian Breast & Colorectal Cancer Study Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
